Nicotinamide for prevention of nonmelanoma skin cancers: a change in practice?

Clin Exp Dermatol. 2017 Dec;42(8):945-946. doi: 10.1111/ced.13244. Epub 2017 Oct 16.

Authors

L Nestor¹, J Clowry¹, K Molloy¹, M Connolly¹, A Salim¹, A M Tobin¹

Affiliation

¹ Department of Dermatology, Tallaght Hospital, Tallaght, Dublin, Ireland.

PMID: 29044731
DOI: 10.1111/ced.13244

No abstract available

Publication types

Randomized Controlled Trial

MeSH terms

Carcinoma, Basal Cell / drug therapy
Carcinoma, Basal Cell / epidemiology
Carcinoma, Basal Cell / prevention & control*
Carcinoma, Squamous Cell / drug therapy
Carcinoma, Squamous Cell / epidemiology
Carcinoma, Squamous Cell / prevention & control*
Cost of Illness
Humans
Keratosis, Actinic
Niacinamide / administration & dosage
Niacinamide / economics
Niacinamide / therapeutic use*
Secondary Prevention / methods
Skin Neoplasms / drug therapy*
Skin Neoplasms / epidemiology
Skin Neoplasms / prevention & control*
Vitamin B Complex / adverse effects
Vitamin B Complex / therapeutic use

Substances

Vitamin B Complex
Niacinamide